BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6220190)

  • 21. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
    Dewis P; Prasad BK; Anderson DC; Willets S
    Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic progress--review VII. The medical treatment of Paget's disease.
    Sheppard MC
    J Clin Hosp Pharm; 1983 Mar; 8(1):35-44. PubMed ID: 6221033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY; Lecart MP
    Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
    Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
    Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Paget's disease of bone.
    Melick RA
    Med J Aust; 1985 Oct; 143(9):394-7. PubMed ID: 2932626
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 28. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
    Gibbs CJ; Aaron JE; Peacock M
    Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate.
    Delmas PD; Chapuy MC; Edouard C; Meunier PJ
    Am J Med; 1987 Aug; 83(2):276-82. PubMed ID: 3113247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical aspects and therapy of Paget's disease (osteitis deformans)].
    Ringe JD
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1207-12. PubMed ID: 6223799
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
    Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Paget's disease of bone.
    Chakravorty NK
    Gerontology; 1979; 25(3):151-8. PubMed ID: 155550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Paget's disease of bone.
    Evans RA
    Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paget's disease of bone.
    Haddad JG
    Curr Ther Endocrinol Metab; 1994; 5():525-7. PubMed ID: 7704787
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC; Khairi MR; Meunier PJ
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Paget's disease of bone.
    Singer FR
    Postgrad Med; 1975 Mar; 57(3):117-20. PubMed ID: 123333
    [No Abstract]   [Full Text] [Related]  

  • 39. Paget's disease of bone: assessment and management.
    Ibbertson HK; Fraser TR; Scott DJ; Cullen JC; Henley JW; Stephens ES; Tait B; Wattie DJ
    Drugs; 1979 Jul; 18(1):33-47. PubMed ID: 157870
    [No Abstract]   [Full Text] [Related]  

  • 40. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
    MacGowan JR; Pringle J; Morris VH; Stamp TC
    Skeletal Radiol; 2000 May; 29(5):279-82. PubMed ID: 10883448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.